Status:
TERMINATED
Pharmacokinetics and Pharmacdynamics of Sildenafil
Lead Sponsor:
Children's Hospital of Philadelphia
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
28+ years
Brief Summary
The study is being done to investigate what happens to sildenafil in the body and how long it takes to get rid of this drug. Understanding how long the drug stays in the body and how it is changed by ...
Detailed Description
There is no data regarding sildenafil drug disposition in infants and children with pulmonary hypertension. Sildenafil is used at The Children's Hospital of Philadelphia for the treatment of pulmonary...
Eligibility Criteria
Inclusion
- Receive enteral sildenafil as standard of care
- \> 28 days to \>18 years of age
- Informed consent/assent
Exclusion
- Parents/guardians and/or subjects who, in the opinion of the investigator, may be noncompliant with study schedules or procedures.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00718185
Start Date
May 1 2008
End Date
February 1 2010
Last Update
March 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104